Equillium Bio (EQ): Earnings growth forecast for next year
The projection of Equillium, Inc. (EQ) EPS for the next year on this GURU.Markets chart demonstrates a value of -19.30. Equillium, Inc. (EQ) creates unique immunomodulators, aiming for a monopoly position in its segment. The business focuses on psoriasis and nephrosis therapy via CD6 receptor blocking for rheumatologists. Further progress is based on the results of molecule clinical trials and stable external funding.
EQ (Equillium Bio): analytical breakdowns and indicator data
- share price and consensus valuation forecast:
- stock exchange capitalization data:
- book capitalization indicators:
- issuer credit burden and liquidity indicators:
Total Debt to Capital Equillium, Inc.|EQ - Ratio of Long-Term Indebtedness to Capital|Short-Term Debt to Equity Equillium, Inc.|EQ - Company Debts|Debt to Book Capitalization Ratio Equillium Inc|EQ - Company Long-Term Debt|Company Short-Term Debts Equillium|Quick Liquidity Indicator equilliumbio.com
- net income and valuation ratios data:
EQ - Net Profit|Expected Profit Equillium, Inc.|EQ - Price to Earnings Ratio|Projected Price to Earnings equilliumbio.com|EQ - Growth-Adjusted Payback Ratio|EV/EBITDA Multiple EQ|EQ - Operating income before deduction of amortization|Earnings per share for the last twelve months Equillium|EQ - Earnings per share for the last 12 months|Quarterly EPS earnings growth equilliumbio.com|EQ - Net earnings per share growth this year|Expected earnings per share growth for next year Equillium, Inc.
- sales and revenue data:
Summary company analysis:EQ, Equillium
This indicator reflects the analysts' consensus forecast for net profit growth rates for the coming year, measuring expected capital efficiency. Investors utilize the 12-month forward EPS growth vector to decouple short-term volatility from the fundamental earnings trend. For Equillium, Inc. (EQ), such price action depends directly on the successful completion of Phase II trials for immunomodulating antibodies.
Key competitors
Expected earnings per share growth for next year ARGX|Earnings growth forecast for next year biontech.de|Net earnings per share growth forecast for next year Abivax Corp (ABVX)|ADMA Biologics, Inc. - Projected earnings per share growth rate for next year|Earnings growth forecast for next year PTGX (protagonist-inc.com)|Immunovant Corp (IMVT) - Expected net earnings per share growth next year|KNSA - Net earnings per share growth forecast for next year|Net earnings per one share growth forecast for next year grifols.com (GRFS)|ADPT: Earnings growth forecast for next year|Expected net earnings per share growth next year Celldex Therapeutics Inc (CLDX)|Net earnings per share growth forecast for next year Aurinia Pharma|Expected net earnings per share growth next year BioCryst Pharmaceuticals Inc BCRX|Earnings growth forecast for next year VERA|Dianthus Therapeutics, Inc. - Projected earnings per share growth rate for next year|Pharvaris - Expected earnings per share growth for next year|AbCellera Biologics Inc. - Net earnings per share growth forecast for next year|Tourmaline Bio Inc - Earnings growth forecast for next year|Net earnings per one share growth forecast for next year Intrexon (PGEN)|Pharming Group (PHAR) - Net earnings per share growth forecast for next year|Nektar Therapeutics Inc. - Expected earnings per share trend next year|Expected earnings per share growth for next year UPB|Zenas Bio (ZBIO) - Consensus forecast of earnings per share growth for next year|Expected earnings per share growth for next year IMNM (Immunome Corp)|GOSS (Gossamer Corp) - Expected earnings per share trend next year|Net earnings per share growth forecast for next year KalVista Pharmaceuticals Inc KALV|Consensus forecast of earnings per share growth for next year septerna.com (SEPN)|PVLA - Net earnings per share growth forecast for next year|Consensus forecast of earnings per share growth for next year Savara Inc SVRA|RIGL: Earnings growth forecast for next year|ANAB - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Astria Pharma|Projected earnings per share growth rate for next year ENGN (enGene Holdings Inc.)|Expected earnings per share growth for next year RAPT (RAPT Therapeutics, Inc.)|Earnings growth forecast for next year Aerovate Therapeutics, Inc. (JBIO)|Earnings growth forecast for next year ACRS (aclaristx.com)|Kyverna Therapeutics (KYTX) - Expected net earnings per share growth next year|tizianalifesciences.com - Earnings growth forecast for next year|CABA (Cabaletta Bio, Inc.) - Projected earnings per share growth rate for next year|VTYX: Earnings growth forecast for next year|THTX - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year Avalo Therapeutics Inc|Eledon (ELDN) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year agenusbio.com (AGEN)|CLYM (Climb Bio Inc) - Expected earnings per share trend next year|Earnings growth forecast for next year ZURA (zurabio.com)|Expected earnings per share trend next year ATYR|ADAG - Net earnings per share growth forecast for next year|ikenaoncology.com (IMA) - Expected earnings per share growth for next year|Shattuck Labs (STTK) - Net earnings per share growth forecast for next year|Net earnings per share change forecast for next year CNTB (Connect Biopharma Holdings)|Expected earnings per share growth for next year IMUX|ATRA (atarabio.com) - Projected earnings per share increase next year|Earnings growth forecast for next year IFRX|Earnings growth forecast for next year X4 Pharma (XFOR)|Adicet Bio Inc. - Expected earnings per share growth for next year|Earnings growth forecast for next year celularity.com CELU|INMB: Expected earnings per share growth for next year|BRNS: Net earnings per share growth forecast for next year|KZR: Earnings growth forecast for next year|SAB Biotherapeutics Inc - Expected earnings per share trend next year|AKTX (Akari Therapeutics, Plc) - Earnings growth forecast for next year|ENLV: Expected earnings per share trend next year|Net earnings per share growth forecast for next year Q32 Bio (QTTB)|Expected earnings per share growth for next year GeoVax Labs GOVX|Earnings growth forecast for next year EDSA (Edesa Biotech Corp)|iBio, Inc. (IBIO) - Expected net earnings per share growth next year|CARM: Expected earnings per share growth for next year|XTL Biopharmaceuticals (XTLB) - Expected earnings per share growth for next year|BOLT: Earnings growth forecast for next year|Expected earnings per share growth for next year HCW Biologics Inc.|Net earnings per share growth forecast for next year aptevotherapeutics.com|AIM: Expected earnings per share trend next year|Net earnings per share growth forecast for next year aditxt.com (ADTX)|GRI - Expected net earnings per share growth next year|Earnings growth forecast for next year XRTX (XORTX Therapeutics Inc)|ReShape Lifesciences (HIND) - Expected net earnings per share growth next year|REVB - Net earnings per share growth forecast for next year|INDP - Earnings growth forecast for next year|SCNI: Earnings growth forecast for next year|Expected earnings per share growth for next year CalciMedica Inc|AFMD (Affimed Therapeutics) - Earnings growth forecast for next year|allakos.com (ALLK) - Consensus forecast of earnings per share growth for next year|Net earnings per share growth forecast for next year HOOKIPA Pharma Inc. (HOOK)|IGM Biosciences Inc. (IGMS) - Net earnings per one share growth forecast for next year|Net earnings per share growth forecast for next year iteostherapeutics.com ITOS|OCEA - Expected earnings per share growth for next year|TC BioPharm (Holdings) Plc - Earnings growth forecast for next year|Expected earnings per share trend next year THRD (Third Harmonic Bio, Inc.)
